Privia Health Group, Inc. ( (PRVA) ) has released its Q2 earnings. Here is a breakdown of the information Privia Health Group, Inc. presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Privia Health Group, Inc. is a leading physician enablement company in the United States, specializing in building provider networks with primary-care centric medical groups and offering a comprehensive suite of technology and service solutions.
Privia Health Group reported robust financial results for the second quarter of 2025, showcasing significant growth across key metrics. The company experienced strong performance in practice collections and adjusted EBITDA, prompting an upward revision of its full-year guidance.
Key highlights from the report include a 23.4% increase in total revenue to $521.2 million and an 18.5% rise in practice collections compared to the same period last year. Despite a decline in operating income and net income, the company reported a 31.6% increase in adjusted EBITDA, reaching $29.0 million. The number of implemented providers grew by 13.8%, and attributed lives increased by 15.2%.
Privia Health’s strategic expansion into the Arizona market, along with a strong sales and business development pipeline, has contributed to its positive outlook. The company holds $390.1 million in cash with no debt, following a $95 million investment in the IMS transaction.
Looking ahead, Privia Health has raised its full-year 2025 guidance above the high end of its previous range for several key metrics, including practice collections and adjusted EBITDA. The company remains focused on expanding its provider network and enhancing its platform to drive continued growth and improved healthcare outcomes.